Tata India Pharma & Healthcare Fund Regular Growth
3Y Annualised
20.31%
0.52% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
2.24%
0.52% 1D
Benchmark
SBI Nifty 10 yr Benchmark G-Sec ETF
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
3 years 9 months
5 years 7 months
9 years 7 months
Fund info
Fund size
₹1183.65 Cr
Min. SIP amount
₹100
Min. Lumpsum amount
₹5000
Exit load
0.0025%
0.25% of NAV if redeemed on or before expiry of 30 days from the date of allotment.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Quant Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
2nd
Quant Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
3rd
Quant Healthcare Fund Direct Growth
4th
Quant Healthcare Fund Regular Reinvestment Inc Dist cum Cap Wdrl
5th
Quant Healthcare Fund Regular Payout Inc Dist cum Cap Wdrl
13th
Tata India Pharma & Healthcare Fund Regular Growth
Fund Managers
About Tata India Pharma & Healthcare Fund Regular Growth
Tata India Pharma & Healthcare Fund Regular Growth is a Equity mutual fund scheme from Tata Asset Management Limited. This fund has been in existence for 9 years, having been launched on 2015-12-28. Tata India Pharma & Healthcare Fund Regular Growth has ₹1183.65 Cr worth of assets under management (AUM) as of Sat Apr 26 2025. The latest Net Asset Value (NAV) of Tata India Pharma & Healthcare Fund Regular Growth as of Fri Apr 25 2025 is ₹29.2109. The fund has an expense ratio of 2.17%, which is medium comparable to most other Equity funds.
Tata India Pharma & Healthcare Fund Regular Growth returns for the last 1 year are 20.27%. Since launch, it has delivered 12.42% average annual returns.
The Tata India Pharma & Healthcare Fund Regular Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of Tata India Pharma & Healthcare Fund Regular Growth.
- Sun Pharmaceuticals Industries Ltd: 11.79%
- Aurobindo Pharma Ltd: 7.27%
- Cipla Ltd: 5.97%
- Apollo Hospitals Enterprise Ltd: 5.66%
- Lupin Ltd: 5.20%
AMC Information
Name | Tata Asset Management Limited |
---|---|
Founding Date | 2015-12-28 |
kiran@tataamc.com | |
Phone | +91 22 6657 8282 |
Website | www.tatamutualfund.com |
Address | Tata Asset Management Private Limited,Mafatlal Centre, 9th Floor,,Nariman Point,,India |
Tax Implications of Tata India Pharma & Healthcare Fund Regular Growth
Short Term Gains | 20% + applicable Surcharge + 4% Cess |
---|---|
Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from Tata Asset Management Limited

EquityLarge & Mid-Cap
3Y CAGR
16.85%
expense ratio
1.67%
fund size
₹8057.61 Cr

Fixed IncomeShort Duration
3Y CAGR
6.67%
expense ratio
1.20%
fund size
₹2834.49 Cr

AllocationEquity Savings
3Y CAGR
9.45%
expense ratio
1.14%
fund size
₹264.77 Cr

EquityMid-Cap
3Y CAGR
18.67%
expense ratio
1.88%
fund size
₹4333.24 Cr

EquityValue
3Y CAGR
19.74%
expense ratio
1.67%
fund size
₹8003.86 Cr
FAQs
What is the current NAV of Tata India Pharma & Healthcare Fund Regular Growth?

What are the average returns of Tata India Pharma & Healthcare Fund Regular Growth?

How do I invest in Tata India Pharma & Healthcare Fund Regular Growth?

What is the expense ratio of Tata India Pharma & Healthcare Fund Regular Growth?

What are net assets under management (AUM) of Tata India Pharma & Healthcare Fund Regular Growth?

What is the PE and PB ratio of Tata India Pharma & Healthcare Fund Regular Growth?

What are the top 5 holdings of Tata India Pharma & Healthcare Fund Regular Growth?

What are the top 3 sectors that Tata India Pharma & Healthcare Fund Regular Growth has invested in?

Who is the manager of Tata India Pharma & Healthcare Fund Regular Growth?

What is the exit load of Tata India Pharma & Healthcare Fund Regular Growth?

How to Redeem Tata India Pharma & Healthcare Fund Regular Growth?

Can I invest in SIP and a Lump Sum of Tata India Pharma & Healthcare Fund Regular Growth?
